SCHEMBL6983335

SCHEMBL6983335

CCOC(=O)C1(c2cccs2)OCC2(CO1)c1ccccc1-c1ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 4/20 0.34
TSHR P16473 3/20 0.34
MAPT P10636 2/20 0.34
PKM P14618 2/20 0.34
BLM P54132 2/20 0.34
GLA P06280 2/20 0.34
GRM1 Q13255 1/20 0.34
PMP22 Q01453 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
NFKB1 P19838 1/20 0.34
CYP2C19 P33261 1/20 0.34
RECQL P46063 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7831174 0.88 HSD11B1 (0.36) SMN1; SMN2ALDH1A1MAPTLMNAL3MBTL1
SCHEMBL6978402 0.86 OPRM1 (0.41) HSD17B10SMN1; SMN2GLAL3MBTL1CTDSP1
SCHEMBL6981485 0.82 THRB (0.38) ALDH1A1MAPTLMNAKMT2A
SCHEMBL6979007 0.80 OPRM1 (0.41) SMN1; SMN2KDM4EALDH1A1TSHRMAPT
SCHEMBL6978137 0.78 OPRM1 (0.43) SMN1; SMN2KDM4EALDH1A1MAPTLMNA
SCHEMBL6975131 0.77 MAPT (0.41) SMN1; SMN2KDM4EALDH1A1MAPTLMNA
SCHEMBL7145811 0.72 APP (0.38) SMN1; SMN2ALDH1A1MAPTGLALMNA
SCHEMBL6976939 0.71 GAA (0.44) SMN1; SMN2KDM4EALDH1A1MAPTBLM
SCHEMBL4114518 0.71 MAPT (0.40) SMN1; SMN2KDM4EALDH1A1TSHRMAPT
SCHEMBL7816365 0.70 MAPT (0.40) SMN1; SMN2ALDH1A1MAPTCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed